Pelvic Health

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Ferring Pharmaceuticals, Rebiotix, a Ferring Company, and MyBiotics Pharma today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility. The collaboration is an important step forward in harnessing the power of the human microbiome in this area…

Spain-based Endometrial Cancer Diagnostics Company MiMark Receives €1.5M Investment from EIT Health

Barcelona-based company MiMARK has received €1.5M in funding from EIT Health following the EIT Health Wild Card program. The company is working on improving accuracy and efficiency of diagnostics for endometrial cancer. Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological…

Women’s Health Biotech Company Aspira Plans to Raise $45M with Its Recently Announced Public Offering of Common Stock

Aspira, a bio-analytical based women’s health company focused on gynecologic disease, has announced plans to raise $45 million through a public offering of common stock. The company intends to use the net proceeds from the offering for sales and marketing, working capital and other general corporate purposes, including investing in additional key strategic hires, product portfolio expansion and research and development. Aspira…

Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities in Cervical Cancer Screening

Hologic announced today a multi-year strategic collaboration with Google Cloud that will feature the integration of Google Cloud’s machine learning (ML) technologies with Hologic’s cutting-edge Genius Digital Diagnostics System to transform screening and accelerate the eradication of cervical cancer across the globe. Genius Digital Diagnostics is the first digital cytology platform to combine artificial intelligence (AI) with advanced digital imaging to help identify pre-cancerous…

Launched: GLISSANT, A New Line of Modern, Natural Lubricants Created by a Female Pelvic Surgeon

As a physician specializing in female pelvic medicine at Cedars-Sinai, one of the country’s leading research hospitals, Dr. Karyn Eilber often heard patients say they avoided sexual activity due to pain and vaginal dryness. Women frequently asked for a natural, non-irritating lubricant without hormones or harsh chemicals, yet there was nothing on the market she could confidently recommend. Frustrated by the lack…

Moon Mother Hemp Founder Jessica Bates: “I didn’t see anything on the market that spoke specifically to the needs of women and vaginal health.”

Women-founded luxury CBD brand Moon Mother Hemp has created a new way to support sexual and vaginal health and a safe and pleasurable way in which to bring CBD into the bedroom. Intimacy Oil is a rapidly emerging category in the hot CBD marketplace. Moon Mother Hemp has created a lubricant, that’s pure and expertly curated. Its ethically sourced ingredients are intentionally blended…

Feminine Intimate Care Brand Queen V Is Acquired by Reckitt Benckiser

U.K.based personal hygiene company Reckitt Benckiser has announced the acquisition of intimate care brand Queen V last week. Queen V has been around since 2018 and offers a selection of vaginal hygiene and health products. The company was backed by Lightspeed Venture Partners, and has sold products at Walmart and CVS. Queen V will now join Reckitt Benckiser’s health global business, that’s…

Femtech Company MobileODT is Awarded a $2.3M Grant from the National Cancer Institute

MobileODT, a femtech company innovating in cervical screening, has been awarded a prestigious Small Business Innovation Research Authority grant of $2.3 million. This grant is presented by the United States National Cancer Institute (NCI) to leading companies that are technologically and clinically advanced to support the NCI’s goal of reducing suffering and death due to cancer. This grant is a tribute to the…